A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Jeevantyadi Taila Nasya,Shatahwadi Ghritha Tarpana and Rasayana Ghana Vati oral intake in Vataja Timira with special reference to Dry Age related Macular Degeneration
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
Age related Macular Degeneration is a major cause of irreversible central vision loss in the elderly, with limited effective treatment options in contemporary ophthalmology. Existing therapies provide suboptimal outcomes and lack strong evidence of long term benefit. Therefore , there is a need to explore safe , effective and evidence based alternative interventions to improve visual function and quality of life in patients with ARMD.
This study aims to check whether Jeevantyadi Taila Nasya and Shatahwadi Ghritha Tarpana along with Rasayana Ghana Vati oral intake is effective in the management of Vataja Timira with special reference to Dry Age -related macular degeneration as compared to that ofprevalent Multivitamin and Antioxidant supplement therapy?
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients presenting with classical signs and symptoms of Vataja Timira i.e. blurred vision (Avila darshana), distorted vision (Vyavidham darshana), central scotoma (Pashyathi asyam anasikam), metamorphopsia (Vakram riju api manyate) 2.Early to intermediate forms of Dry AMD ie presence of Drusens and AMD changes in retina.
排除标准
- •Presence of any other retinal or macular pathology other than Non-Exudative AMD such as Exudative AMD Diabetic retinopathy Central geographic atrophy Hemorrhagic condition of fundus or retinal fluid.
- •History of retinal laser or surgical therapy in study eye.
- •Contraindication of pupil dilatation in the study eye.
- •Mature cataract or media opacification in either eye which limits an adequate view of fundus.
- •Unable to maintain stable fixation for OCT imagining.
- •Patient having systemic disorders that may confound or alter the course of AMD.
- •Patients who are contraindicated for any of the trial or control drugs.
研究者
Dr Sharanya A
National Institute of Ayurveda